Clinical Trials Directory

Trials / Completed

CompletedNCT03322098

Effect of Atropine or Glycopyrrolate on the Prevention of Bradycardia During Sedation Using Dexmedetomidine in Geriatric Patients Undergoing Total Knee Replacement Under Spinal Anesthesia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Patients undergoing total knee arthroplasty with spinal anesthesia are often sedated to reduce patient discomfort due to large noises during surgery and also to reduce anxiety. Most commonly used sedatives include propofol and midazolam, but these agents often cause hypotension or respiratory depression, especially in elderly patients. Dexmedetomidine is a selective alpha 2 adrenergic drug, which acts as a sedative and also has analgesia effects. In contrast to propofol or midazolam, dexmedetomidine rarely causes respiratory depression, and therefore is often used in critically ill patients in the ICU and also in patients undergoing simple procedures. Hemodynamically, dexmedetomidine evokes a biphasic blood pressure response with a short hypertensive phase and subsequent hypotension. Bradycardia is also observed in many patients, which may lead to more serious outcomes in elderly patients who often have multiple comorbidities. Therefore, drugs to prevent bradycardia during dexmedetomidine infusion may help patients maintain a more stable hemodynamic state. The present study aims to compare the ability of atropine and glycopyrrolate to prevent bradycardia during dexmedetomidine infusion in elderly patients undergoing knee surgery with spinal anesthesia.

Conditions

Interventions

TypeNameDescription
DRUGAtropineAtropine injection (0.01 mg/kg, max 0.5 mg) within 3 minutes before spinal anesthesia
DRUGGlycopyrrolateGlycopyrrolate (0.00 4mg/kg, max 0.2 mg) within 3 minutes before spinal anesthesia

Timeline

Start date
2017-10-16
Primary completion
2018-05-15
Completion
2018-05-15
First posted
2017-10-26
Last updated
2018-09-24

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03322098. Inclusion in this directory is not an endorsement.